|
The COVAX Maternal Immunization Working Group (MIWG): co-chaired by Drs. Flor M. Munoz (Baylor College of Medicine, USA) and Ajoke Sobanjo-ter Meulen (Bill & Melinda Gates Foundation, USA) includes a group of professionals with expertise in various aspects pertinent to maternal immunization, who represent diverse organizations, geographies, and settings. The aim of the MIWG is to enable the evaluation and utilization of COVID-19 vaccine candidates in pregnant and lactating women. Co-Leads: Ajoke Sobanjo-Ter Meulen (BMGF), Flor Muñoz (Baylor College of Medicine) | List of members |
 |
COVAX > Clinical Development and Operation > Maternal Immunization > Publications
Publications
COVID-19 and pregnancy - risks to mothers and infants when developing COVID-19 while pregnant or lactating
COVID-19–Associated Deaths After SARS-CoV-2 Infection During Pregnancy — Mississippi, March 1, 2020–October 6, 2021; CDC Mortality and Morbidity Report | Laurin Kasehagen et al. | 19 Nov 2021
Risk for Stillbirth Among Women With and Without COVID-19 at Delivery Hospitalization — United States, March 2020–September 2021; CDC Mortality and Morbidity Report | Carla L. DeSisto et al. | 19 Nov 2021
COVID-19 Severity among Women of Reproductive Age with Symptomatic Laboratory-Confirmed SARS-CoV-2 by Pregnancy Status – United States, Jan 1, 2020 – Sep 30, 2021 | Penelope Strid et al. | 18 Nov 2021
Maternal and Perinatal Outcomes Associated With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta (B.1.617.2) Variant | Angela R. Seasely | 22 Oct 2021
Prevalence of Maternal Mortality and Clinical Course of Maternal Deaths in COVID‑19 Pneumonia‑A Cross‑Sectional Study | Mahesh Asalkar et al. | 06 Oct 2021
Characteristics and outcomes of pregnant women with SARS-CoV-2 infection and other severe acute respiratory infections (SARI) in Brazil from January to November 2020 | Lisiane F. Leal | Sep 2021
Impact of SARS-CoV-2 variant on the severity of maternal infection and perinatal outcomes: Data from the UK Obstetric Surveillance System national cohort. | Nicola Vousden et al. | 25 Jul 2021
COVID-19 poses alarming pregnancy and postpartum mortality risk in Brazil | Susie Gurzenda et al. | 30 May 2021
Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study | Ipek Gurol-Urganci | 14 May 2021
Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection - The INTERCOVID Multinational Cohort Study | José Villar et al. | 22 Apr 2021
COVID-19 in Pregnant Women and Their Newborn Infants | C. Mary Healy | 22 Apr 2021
Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis | Barbara Chmielewska | 31 Mar 2021
Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis | John Allotey et al. | 2 Feb 2021
COVID-19 vaccines and pregnancy - data from pregnancies or lactation period in vaccinated women
Global Disparities in Public Health Guidance for the use of COVID-19 Vaccines in Pregnancy | Eleonor Zavala et al. | Oct 2021
Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion | Lauren H. Zauche et al. | 8 Sep 2021
Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy | Noa Dagan et al. | 07 Sep 2021
Alignment of national COVID-19 vaccine recommendations for pregnant and lactating women | Michelle L Giles et al. | 30 Aug 2021
Short-term Reactions Among Pregnant and Lactating Individuals in the First Wave of the COVID-19 Vaccine Rollout | Alisa Kachikis et al. | 17 Aug 2021
Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review | Agustín Ciapponi et al. | 13 Aug 2021
Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women | Inbal Goldshtein et al. | 12 Jul 2021
Evaluation of Messenger RNA From COVID-19 BTN162b2 and mRNA-1273 Vaccines in Human Milk | Ahituv Golan et al. | 6 Jul 2021
COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy — Eight Integrated Health Care Organizations, United States, December 14, 2020–May 8, 2021 | Hilda Razzaghi et al. | 18 Jun 2021
mRNA Covid-19 Vaccines in Pregnant Women | Laura E. Riley | 17 Jun 2021
EBCOG position statement on COVID-19 vaccination for pregnant and breastfeeding women | Inês Martins et al. | 14 May 2021
Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons | Tom T. Shimabukuro et al. | 21 Apr 2021
|
Other tools and Guidance |